January in Review
Here's all the news you might have been missing.

January in Review

What's Going on at SCOPE 2024? Love Bytes.

Visit Booth #906 for Love Bytes, our RBQM platform demo, to automatically enter into a Valentine’s Day giveaway (hint: gold-dipped by the dozen!). In the meantime, register for our free TopGolf event. Lastly, don't miss our presentation?Does Quality Actually Improve with RBQM? A Review of New Evidence presented by Steve Young, CSO, on Monday, February 12th at 10:50 am.

A Year in Review: 2023 as a Watershed Moment in the Evolution of Clinical Data Management

Clinical data management progressed with the inclusion of RBQM in ICH E6 (R3) and widespread AI adoption, highlighting the importance of education for achieving Research 2.0 in 2024 and beyond. Read more.

The Risk-Based Data Management (RBDM) Revolution

?In this session, we’ll demonstrate how RBQM, within the broader framework of RBDM, flags systemic data issues that traditional approaches might overlook, ensuring data quality and participant safety. Register here.

Do You Even Science?

We’re joining a panel of industry experts to illustrate one of the most important critical success factors in clinical research: Ensuring that research is executed exactly as designed by the Sponsor. Don't miss out!

What Is Trending in Data Management & AI??

We’re seeing the widespread adoption of machine and deep learning, especially in clinical research. The most impactful usage combines AI automation with human critical thinking for efficiency and accuracy.?Learn more.

RBQMLIVE ON-DEMAND: The ABCs of ICH E6 (R3): Understanding the Guidance Updates

?ICH E6 (R3) is crafted for versatility across diverse clinical trials, urging thoughtful adaptation to tackle distinct challenges such as trial features, investigational products, and participant demographics.?Watch today.


Unlock the future of clinical trials with CluePoints!

Contact us for a personalized demo and discover advanced RBQM solutions powered by Central Statistical Monitoring.

要查看或添加评论,请登录

CluePoints的更多文章

社区洞察

其他会员也浏览了